Usv Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
One of their notable products is IMIQUIMOD USP, with a corresponding US DMF Number 20353.
Remarkably, this DMF maintains an Active status since its submission on April 05, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 28, 2013, and payment made on August 16, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II